Heterogeneous Vancomycin Intermediate Staphylococcus aureus Infections in Diabetic and Non-Diabetic Patients - A Hospital-Based Comparative Study.
Sreejisha MShalini Shenoy MulkiSuchitra M ShenoyBiranthabail DhanashreeChakrapani MGopalakrishna BhatPublished in: Infection and drug resistance (2023)
The rate of hVISA among all MRSA isolates was 6.4%. The risk of hVISA infection was three times more in diabetic patients. The results emphasize the importance of the detection of hVISA among MRSA isolates especially from diabetic patients.